Integrator Complex Subunit 2 (INTS2) (N-Term) Peptide
Quick Overview for Integrator Complex Subunit 2 (INTS2) (N-Term) Peptide (ABIN2183020)
Target
Origin
Source
Application
-
-
Protein Region
- N-Term
-
Sequence
- VCRGLIKNGE RQDEESLGGR RRTDALRFLC KMNPSQALKV RGMVVEECHL
-
Characteristics
- This is a synthetic peptide designed for use in combination with anti-INTS2 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Purification
- Purified
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Concentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Handling Advice
- Avoid repeat freeze-thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- INTS2 (Integrator Complex Subunit 2 (INTS2))
-
Background
-
INTS2 is a subunit of the Integrator complex, which associates with the C-terminal domain of RNA polymerase II large subunit (POLR2A, MIM 180660) and mediates 3-prime end processing of small nuclear RNAs U1.
Alias Symbols: INT2, KIAA1287
Protein Size: 1204 -
Molecular Weight
- 134 kDa
-
Gene ID
- 57508
-
NCBI Accession
- NM_020748, NP_065799
-
UniProt
- Q9H0H0
Target
-